OncoLink Cancer Treatment and Resources

 
A Randomized Phase II Trial Comparing RhuMAb VEGF (Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Cell Growth Factor) Plus Carboplatinum/Paclitaxel (CP) to CP Alone in Patients with Stage IIIB/IV Non-small Cell Lung Cancer
Presenter: Russel DeVore, MD Affiliation: Vanderbilt University Background: For advanced and metastatic non-small cell lung cancer, current therapies are limited. These therapies at best may offer patients survival benefits on the order of...
ASCO Broadcasts Unique Interactive Forum Live
On Monday morning, ASCO tested new ground by broadcasting its first-ever satellite-fed live session on patient-physician communication to more than 425 hospitals and medical centers nationwide. The session itself, which was attended by a few...
Comparative Cost-Effectiveness of Paclitaxel-Cisplatin (TP) vs Cyclophosphamide-Cisplatin (CP) in Women with Advanced Epithelial Ovarian Cancer: Results from a Randomized Trial.
Presenter: Hugh Walker Affiliation: Queens Univ, Kingston, NC, Canada Background: Postoperative paclitaxel and cisplatin (TP) chemotherapy improves survival compared with cyclophosphamide and cisplatin (CP) in patients with advanced...
Continued Response Following Treatment with IMC-C225, an EGFr MoAb, Combined with RT in Advanced Head and Neck Malignancies.
Presenter: James A. Bonner Affiliation: University of Alabama, ImClone Background: Radiation therapy with or without chemotherapy is standard therapy for locally advanced head and neck squamous cell cancer Because of the relatively...
Forum on Clinical Trials and Public Perception Focuses on the Role of the Media
"No disease has been cured as many times as cancer has." -Ellen Stovall, National Coalition for Cancer Survivorship (NCCS), quoting Rick Weiss of The Washington Post The media plays a pivotal role in shaping public perceptions of cancer...
Impact of Tumor Control on Survival in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Concurrent Thoracic Radiotherapy (TRT) and Chemotherapy (CT).
Presenter: K. Furuse Affiliation: Health Insurance Union Osaka Cent Hosp, Osaka Background: Radiation therapy and chemotherapy is standard therapy in good performance status patients with locally advanced unresectable non-small cell...
OncoLink I wish u knew...

Dr. O'Dwyer discusses pancreatic cancer, family history, screening and future research. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS